Acute Myelogenous Leukemia

Showing 26 - 50 of 203

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

Terminated
  • Acute Myelogenous Leukemia
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Mar 17, 2022

Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +2 more
  • (no location specified)
Mar 3, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • XmAb14045
    • Jacksonville, Florida
    • +8 more
    Mar 4, 2022

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • FT-2102 (olutasidenib)
    • +2 more
    • Los Angeles, California
    • +59 more
    Mar 2, 2022

    Acute Myelogenous Leukemia, MDS Trial in Shanghai (Gentulizumab)

    Recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndromes
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Feb 22, 2022

    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • +10 more
    • Atlanta, Georgia
    • +2 more
    Feb 9, 2022

    Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan

    Active, not recruiting
    • Myeloid Malignancies
    • +4 more
    • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
    • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Feb 25, 2022

    Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Gilbert, Arizona
    • +23 more
    Feb 22, 2022

    Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))

    Recruiting
    • Leukemia
    • +5 more
    • Bone Marrow Transplant (BMT)
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Feb 14, 2022

    Cancer, Acute Lymphoblastic Leukemia, Lymphoma Trial in Seattle (Promoting Resilience In Stress Management (PRISM))

    Completed
    • Cancer
    • +6 more
    • Promoting Resilience In Stress Management (PRISM)
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 28, 2022

    Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • AML
    • DC AML Vaccine
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 25, 2022

    Acute Myelogenous Leukemia, AML, Advanced MDS Trial in Miami (Pevonedistat, Cytarabine)

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • Miami, Florida
      University of Miami
    Dec 7, 2021

    Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

    Active, not recruiting
    • Hodgkin's Lymphoma
    • +17 more
    • mycophenolate mofetil
    • +2 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    Dec 21, 2021

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Winston-Salem

    Recruiting
    • Acute Myelogenous Leukemia
    • +9 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Health
      Nov 23, 2021

      Acute Myelogenous Leukemia Trial in Boston (decitabine, DC/AML fusion cells)

      Recruiting
      • Acute Myelogenous Leukemia
      • Boston, Massachusetts
      • +1 more
      Nov 15, 2021

      Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

      Active, not recruiting
      • Acute Myelogenous Leukemia
      • Myelodysplastic Syndrome
      • Gemtuzumab Ozogamicin
      • Valhalla, New York
        New York Medical College
      Nov 11, 2021

      Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +4 more
      • Valhalla, New York
      • +1 more
      Oct 29, 2021

      Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

      Completed
      • Acute Myelogenous Leukemia
      • +4 more
      • Single Umbilical Cord Blood Unit Transplant
      • +6 more
      • Birmingham, Alabama
      • +37 more
      Oct 13, 2021

      Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)

      Terminated
      • Acute Myelogenous Leukemia
      • Myelodysplastic Syndrome
      • Duarte, California
      • +4 more
      Sep 14, 2021

      Acute Myelogenous Leukemia Trial in Rochester, Milwaukee (Azacitidine, Venetoclax, Pevonedistat)

      Active, not recruiting
      • Acute Myelogenous Leukemia
      • Rochester, Minnesota
      • +1 more
      Sep 21, 2021

      Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

      Recruiting
      • Myeloid Leukemia, Chronic
      • +8 more
      • Conventional T cells (Tcon) and Regulatory T cells (Treg)
      • Palo Alto, California
        Stanford University School of Medicine Palo Alto, California, Un
      Aug 18, 2021

      Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

      Completed
      • Acute Myelogenous Leukemia
      • +2 more
      • New York, New York
        Columbia University Medical Center
      Aug 4, 2021

      AML, Acute Myelogenous Leukemia Trial (Scaling and Root Planing)

      Not yet recruiting
      • AML
      • Acute Myelogenous Leukemia
      • Scaling and Root Planing
      • (no location specified)
      Aug 3, 2021